|
F. Hoffman-La Roche Limited's Roche Diagnostics Division, established in 1968 and based in Basel, Switzerland, develops screening products that support the identification, analysis, and monitoring of malaria, diabetes, AIDS, SARS, and other diseases. The organization's technology optimizes a wide range of diagnostic and therapeutic health care processes. Roche Diagnostics provides customers with applied science, molecular diagnostics, centralized diagnostics, diabetes care, and near patient testing systems. The firm has developed genetic material replication, serum work analysis, polymerase chain reaction (PCR) detection, blood gas and electrolyte analysis, insulin pump, and other products. It also provides clients with technical support services. The 1998 acquisition of Boehringer Mannheim has allowed the company to serve the in-vitro diagnostics market. The firm acquired Igen and Disetronic in 2003. In the same year, it established strategic alliances with Epigenomics AG, BodyMedia Incorporated, and Affymetrix Incorporated. The company has formed strategic partnerships with information services, veterinary diagnostics developers, medical laboratories, and a variety of other organizations worldwide. Roche Diagnostics employs 19,000 people. The company is focusing on the development of health care systems that integrate test and medical information.
|
Information Sources, Inc.